FindTrial
Sign In

Trial to study the effects of Sertaconazole and electrocautery in localized Tinea Corporis

A Controlled Trial to compare the efficacy and safety of Electrocautery with topical 2% Sertaconazole against topical 2% Sertaconazole alone in the treatment of localized Tinea Corporis: A Pilot Studyâ?? - CTESTC

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032335
Enrollment
30
Registered
2021-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Electrocautery followed by 2% sertaconazole: Electrocautery is done under topical anaesthesia in low power mode (1.5 or 2) followed by twice daily application of 2% sertaconazole 2FTU f

Sponsors

Dept of dermatology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) localised tinea corporis 2) at least 2 lesions 8) willing to be photographed

Exclusion criteria

Exclusion criteria: 1) pregnant and lactating patients 2) patients with pacemakers 3) patients with keloidal and/or hyperpigmentation tendencies 4) patients with hypersensitivity to 2% sertaconazole 5) patients with individual lesions >5 cm 6) patients on systemic antifungal in past 3 months 7) patients on topical antifungal 1 week prior to recruitment 8) disseminated tinea 9) uncontrolled diabetes 10) immunocompromised like HIV-AIDS

Design outcomes

Primary

MeasureTime frame
Erythema, scaling, pruritus, vesiculationTimepoint: 0, 1, 2, 4 weeks—

Secondary

MeasureTime frame
NoneTimepoint: None—

Countries

India

Contacts

Public ContactSumit Sen

IPGME&R and SSKMH

drsumitsen@gmail.com9433960150

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026